Veralto

“just a few weeks ago, we completed the acquisition of In-Situ, expanding our world-class water analytics portfolio in the fast-growing environmental water and hydrology markets.”

Veralto completed the acquisition of In-Situ (~$80M sales, ~8% growth) to expand its environmental water analytics/hydrology portfolio alongside OTT HydroMet.

“We remain excited about our partnership with Emerald, and they are vetting a number of technologies in partnership with us that address treatment, monitoring and emerging contaminants.”

Veralto's investment in Emerald Ventures gives it a partnership vetting water-treatment, monitoring and emerging-contaminant technologies.

“Last week, we announced a EUR 20 million commitment to invest in Emerald Technology Ventures Global Water Fund II to support investments in emerging technology-oriented businesses. Emerald's global presence and deep sector expertise is expected to provide our water quality team with early insights into emerging water-focused ventures, making it a strong strategic partner to augment our innovation and technology development efforts.”

Veralto committed EUR 20 million to Emerald Technology Ventures' Global Water Fund II, a private VC firm, to gain early insight into emerging water-tech ventures — a strategic investment partnership.

“I would think Videojet would be a pretty good real-time demand indicator for really just customer confidence and such.”

An analyst cites Danaher's Videojet brand, a direct competitor in marking and coding, as a real-time read on customer demand and confidence to benchmark against Veralto's own results.

“We remain active with our minority investment in Axione Technologies, which is a destruction technology or PFOS.”

Veralto holds a minority investment in Axione Technologies, a PFAS/PFOS destruction technology company, as part of its strategy to build optionality in emerging water-treatment regulation.

“And in February, we signed a definitive agreement to acquire AQUAFIDES an Austria-based provider of ultraviolet water treatment for $20 million. AQUAFIDES treatment systems are used in drinking water, wastewater and a variety of industrial applications that require high-purity water, including food and beverage and pharmaceuticals.”

Veralto agreed to acquire Austria-based UV water treatment provider AQUAFIDES for $20 million, expanding its Trojan business's European footprint and UV treatment portfolio.

“The integration of TraceGains is on track. Sales are growing in line with our expectations, and we continue to invest in future growth.”

Veralto reports its TraceGains acquisition (packaging/software) is integrating smoothly with sales growth meeting expectations, supporting continued investment in the business.

“you all know I have covered the Danaher for so many years. So whenever I hear about growth investments done at year end, that’s really read out of the Danaher playbook.”

An analyst notes Veralto's year-end growth investments mirror the playbook of its former parent Danaher, which management confirms given its team's Danaher heritage.

“signed an agreement to sell Advanced Vision Technology or AVT, a print inspection product line in our PQI segment with approximately $40 million in annual sales.”

Veralto divested its Advanced Vision Technology (AVT) print inspection product line, a roughly $40 million annual sales business, as part of portfolio pruning.

“we made a minority investment in Axine, a provider of electrochemical oxidation technology, used to destroy contaminants in water including PFAS.”

Veralto made a minority investment in Axine's electrochemical oxidation technology for destroying water contaminants including PFAS.

“As we talked about on our Q3 call, TraceGains was acquired early in the fourth quarter. It is a leading provider of cloud-based software solutions that enable connected data and digital workflow management for consumer brands.”

Veralto acquired TraceGains, a cloud-based digital workflow software provider for consumer brands, its first sizable acquisition, with core sales growing over 20% year over year post-close.